An "ultra-sensitive" new blood test can predict if breast cancer will return years before the disease shows up on scans, ...

A community of breast milk donors has formed in Uganda after women struggled with finding ways to keep their babies with ...

AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by ...

Scientists say it could transform chances of survival by allowing patients to start treatment before the cancer becomes ...

Experts in evidence-based medicine are now recommending women get mammograms every other year starting at 40 years old, which ...

If the babies didn’t get breast milk — which she didn’t have — Ikendi could lose them as well. READ: Hundreds of Filipino ...

A new ultra-sensitive blood test can spot signs of a breast cancer relapse years before it happens. It was found to be 100% accurate during the study by London's Institute of Cancer Research.

AstraZeneca Plc’s lung and breast cancer drugs significantly slowed the spread of disease in two trials, potentially ...

Almost one out of five breast cancer survivors may experience weight gain of more than 10%, suggests a study presented Monday ...

After Enhertu pioneered the HER2-low category in breast cancer treatment, AstraZeneca and Daiichi Sankyo are now hopeful that ...

At ASCO, Astra Zeneca reported that its drug Enhertu stalled the growth of tumors by more than a year in women with the most ...

A new therapy, belonging to an innovative class of drugs, has proven effective against metastatic breast cancer: it is a drug ...